# Clinical Pharmacology of Glucagon.

> PubMed lists PMID 38847591 in Clinical pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38847591-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-07
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38847591-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38847591-glucagon-v1.json
- Content SHA-256: `bf566532a23109fc846c97921f48a96bc6e295e2eeda5b8b5ab21d48a17dc364`

## Claims and source pins

### Headline

Clinical Pharmacology of Glucagon. ([`pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0`](#source-pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0))

### Summary

PubMed lists PMID 38847591 in Clinical pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0`](#source-pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0))

### Paragraph 1

PubMed lists PMID 38847591 in Clinical pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0`](#source-pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0`](#source-pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0))

## Sources

<a id="source-pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0"></a>
- **Clinical Pharmacology of Glucagon. · retained source version 1:2026-07-07:current:1aab80fd2ce0ab3b84123f3710cbc67c11e89ffa107a5dc5d3af718bd8e25f58** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38847591/) (`pubmed-observation-pmid-38847591-2026-07-07-1aab80fd2ce0`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Clinical Pharmacology of Glucagon." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38847591-glucagon-v1.json SHA-256: bf566532a23109fc846c97921f48a96bc6e295e2eeda5b8b5ab21d48a17dc364.